UPDATE: USTR ANNOUNCES THE MODIFICATION OF A 301 LIST 1 PRODUCT

On June 5, 2020, the U.S. Trade Representative (“USTR”) announced the modification of a China 301 List 1 exclusion as described below:

Original Language Amended Language
Machines for crushing/grinding pills, each valued over $20 but not over $35 (described in statistical reporting number 8479.82.0080) Machines for crushing/grinding pills, each valued not over $35 (described in statistical reporting number 8479.82.0080)

Separately, the USTR continues to seek comments identifying additional medical-care items that should be excluded from China Section 301 tariffs in light of the ongoing COVID-19 outbreak (even if a prior exclusion request on an item has been denied or is pending).  The comment period will remain open until at least June 25, 2020.  Additional information can be found at: https://www.gdlsk.com/ustr-soliciting-comments-on-the-removal-of-china-sec-301-duties-from-additional-medical-care-products/?highlight=medical.

If your business is interested in seeking a refund of past duties paid under Section 301, and/or discussing Section 301 mitigation strategies, please contact our office and speak with one of our attorneys.

Twitter
LinkedIn

Additional News

Globe

IEEPA Refund Litigation Update

We sent out an overview of the potential IEEPA refund situation explaining how companies can protect rights to potential IEEPA Tariff refunds. One of the concerns we highlighted is that in

Read More »

Additional Insights